JP2013523180A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523180A5 JP2013523180A5 JP2013505077A JP2013505077A JP2013523180A5 JP 2013523180 A5 JP2013523180 A5 JP 2013523180A5 JP 2013505077 A JP2013505077 A JP 2013505077A JP 2013505077 A JP2013505077 A JP 2013505077A JP 2013523180 A5 JP2013523180 A5 JP 2013523180A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- protein
- cell
- heterologous protein
- endogenous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 claims 27
- 108090000623 proteins and genes Proteins 0.000 claims 27
- 238000000034 method Methods 0.000 claims 18
- 210000004027 cell Anatomy 0.000 claims 13
- 230000002759 chromosomal effect Effects 0.000 claims 10
- 108010042407 Endonucleases Proteins 0.000 claims 6
- 102000004533 Endonucleases Human genes 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 230000001105 regulatory effect Effects 0.000 claims 5
- 102000007469 Actins Human genes 0.000 claims 4
- 108010085238 Actins Proteins 0.000 claims 4
- 108091026890 Coding region Proteins 0.000 claims 4
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims 3
- 241000699802 Cricetulus griseus Species 0.000 claims 2
- 108010047294 Lamins Proteins 0.000 claims 2
- 102000006835 Lamins Human genes 0.000 claims 2
- 102000004243 Tubulin Human genes 0.000 claims 2
- 108090000704 Tubulin Proteins 0.000 claims 2
- 210000000349 chromosome Anatomy 0.000 claims 2
- 238000003776 cleavage reaction Methods 0.000 claims 2
- 210000001672 ovary Anatomy 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 230000007017 scission Effects 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 1
- 230000005782 double-strand break Effects 0.000 claims 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32371910P | 2010-04-13 | 2010-04-13 | |
| US32370210P | 2010-04-13 | 2010-04-13 | |
| US32369810P | 2010-04-13 | 2010-04-13 | |
| US61/323,702 | 2010-04-13 | ||
| US61/323,698 | 2010-04-13 | ||
| US61/323,719 | 2010-04-13 | ||
| US36701710P | 2010-07-23 | 2010-07-23 | |
| US61/367,017 | 2010-07-23 | ||
| US39066810P | 2010-10-07 | 2010-10-07 | |
| US61/390,668 | 2010-10-07 | ||
| US40885610P | 2010-11-01 | 2010-11-01 | |
| US61/408,856 | 2010-11-01 | ||
| US201161431957P | 2011-01-12 | 2011-01-12 | |
| US61/431,957 | 2011-01-12 | ||
| PCT/US2011/032216 WO2011130345A1 (en) | 2010-04-13 | 2011-04-13 | Use of endogenous promoters to express heterologous proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523180A JP2013523180A (ja) | 2013-06-17 |
| JP2013523180A5 true JP2013523180A5 (enExample) | 2014-05-08 |
| JP5841996B2 JP5841996B2 (ja) | 2016-01-13 |
Family
ID=44799004
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013505077A Active JP5841996B2 (ja) | 2010-04-13 | 2011-04-13 | 異種タンパク質を発現するための内因性プロモーターの使用 |
| JP2013505078A Active JP5841997B2 (ja) | 2010-04-13 | 2011-04-13 | 内因性にタグ付けされたタンパク質を生成するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013505078A Active JP5841997B2 (ja) | 2010-04-13 | 2011-04-13 | 内因性にタグ付けされたタンパク質を生成するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US20130059362A1 (enExample) |
| EP (2) | EP2558574B1 (enExample) |
| JP (2) | JP5841996B2 (enExample) |
| KR (2) | KR20130054955A (enExample) |
| CN (3) | CN107805278A (enExample) |
| BR (1) | BR112012026379A2 (enExample) |
| CA (2) | CA2795636C (enExample) |
| DK (1) | DK2558575T3 (enExample) |
| ES (1) | ES2565216T3 (enExample) |
| WO (3) | WO2011130343A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3489359A1 (en) | 2010-07-23 | 2019-05-29 | Sigma Aldrich Co. LLC | Genome editing using targeting endonucleases and single-stranded nucleic acids |
| US9012617B2 (en) * | 2011-04-11 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | Detection reagents for tyrosine kinase activity and methods of use thereof |
| DK3260140T3 (da) * | 2011-12-05 | 2021-04-19 | Factor Bioscience Inc | Fremgangsmåder og produkter til transficering af celler |
| GB201122458D0 (en) | 2011-12-30 | 2012-02-08 | Univ Wageningen | Modified cascade ribonucleoproteins and uses thereof |
| US10274499B2 (en) | 2012-03-27 | 2019-04-30 | The University Of Western Ontario | SH2 domain variants |
| ES2828663T3 (es) * | 2012-04-18 | 2021-05-27 | Univ Leland Stanford Junior | Dirección genética no disruptiva |
| KR101656236B1 (ko) * | 2012-10-23 | 2016-09-12 | 주식회사 툴젠 | 표적 DNA에 특이적인 가이드 RNA 및 Cas 단백질을 암호화하는 핵산 또는 Cas 단백질을 포함하는, 표적 DNA를 절단하기 위한 조성물 및 이의 용도 |
| AU2014235794A1 (en) | 2013-03-14 | 2015-10-22 | Caribou Biosciences, Inc. | Compositions and methods of nucleic acid-targeting nucleic acids |
| CA2939847C (en) | 2014-03-21 | 2023-09-05 | The Board Of Trustees Of The Leland Stanford Junior University | Genome editing without nucleases |
| SI3514172T1 (sl) * | 2014-04-01 | 2020-07-31 | Biontech Cell & Gene Therapies Gmbh | Claudin-6 specifični imunoreceptorji in T-celični epitopi |
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| AU2015342749B2 (en) | 2014-11-07 | 2022-01-27 | Editas Medicine, Inc. | Methods for improving CRISPR/Cas-mediated genome-editing |
| CN107849149A (zh) * | 2015-03-13 | 2018-03-27 | 马里兰大学巴尔的摩分校 | 通用抗体介导的生物传感器 |
| CA2999500A1 (en) | 2015-09-24 | 2017-03-30 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| KR20250141836A (ko) * | 2015-11-04 | 2025-09-29 | 페이트 세러퓨틱스, 인코포레이티드 | 만능 세포의 유전자 조작 |
| KR20180086264A (ko) * | 2015-12-23 | 2018-07-30 | 테크놀로지안 투트키무스케스쿠스 브이티티 오와이 | 세포로부터 인디케이터 신호를 얻는 방법 |
| EP3433363A1 (en) | 2016-03-25 | 2019-01-30 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| EP4047092B1 (en) | 2016-04-13 | 2025-07-30 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
| CN106800602B (zh) * | 2017-01-22 | 2020-05-01 | 中国科学院生物物理研究所 | 一种可视化标记基因组位点的方法 |
| US20190365818A1 (en) * | 2017-02-09 | 2019-12-05 | Allen Institute | Genetically-tagged stem cell lines and methods of use |
| EP3652312A1 (en) | 2017-07-14 | 2020-05-20 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| US11932858B2 (en) | 2017-12-14 | 2024-03-19 | Donald Danforth Plant Science Center | Homologous recombination via transcriptional activation |
| CN112105736A (zh) * | 2018-05-04 | 2020-12-18 | 西格马-奥尔德里奇有限责任公司 | 生产具有降低宿主细胞蛋白水平的重组蛋白 |
| JP7233545B2 (ja) * | 2018-12-30 | 2023-03-06 | エフ． ホフマン－ラ ロシュ アーゲー | 標的タンパク質への検出可能なタグのＣＲＩＳＰＲ／Ｃａｓ制御組み込みに基づく細胞の選択方法 |
| EP4031583A4 (en) * | 2019-09-16 | 2023-11-15 | Fred Hutchinson Cancer Center | CHIMERIC RECEPTOR PROTEINS AND THEIR USES |
| CN113684228B (zh) * | 2021-10-26 | 2022-03-11 | 天九再生医学(天津)科技有限公司 | 利用内参快速准确表征蛋白质相对丰度的方法 |
| CN114703174B (zh) * | 2022-04-12 | 2023-10-24 | 中国科学院海洋研究所 | 快速获得基因型和表型突变的CRISPR/Cas9基因敲除方法及应用 |
| CN115948401A (zh) * | 2022-12-19 | 2023-04-11 | 中国科学技术大学 | 一种多靶点rna靶向敲低系统及应用 |
| CN120177781B (zh) * | 2025-05-22 | 2025-08-12 | 南京师范大学 | 生物传感器及其应用和高通量筛选花姜酮生产菌的方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192772B1 (en) * | 1988-08-31 | 2007-03-20 | The University Of Florida Research Foundations, Inc. | Recombinant cells that highly express chromosomally-integrated heterologous gene |
| US7090976B2 (en) * | 1999-11-10 | 2006-08-15 | Rigel Pharmaceuticals, Inc. | Methods and compositions comprising Renilla GFP |
| US6495664B1 (en) * | 1998-07-24 | 2002-12-17 | Aurora Biosciences Corporation | Fluorescent protein sensors of post-translational modifications |
| US6534261B1 (en) * | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6710170B2 (en) * | 1999-09-10 | 2004-03-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US7125660B2 (en) * | 2000-09-13 | 2006-10-24 | Archemix Corp. | Nucleic acid sensor molecules and methods of using same |
| US7332589B2 (en) * | 2001-09-26 | 2008-02-19 | University Of North Carolina At Chapel Hill | Variants of alpha-fetoprotein coding and expression sequences |
| EP3222715A1 (en) * | 2003-08-08 | 2017-09-27 | Sangamo BioSciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7402436B2 (en) * | 2004-05-03 | 2008-07-22 | City Of Hope | Lentiviral vectors for site-specific gene insertion |
| EP1774330A4 (en) * | 2004-08-02 | 2008-10-15 | Cellumen Inc | METHODS FOR DETECTION OF MOLECULAR INTERACTIONS IN CELLS |
| AU2005287278B2 (en) * | 2004-09-16 | 2011-08-04 | Sangamo Biosciences, Inc. | Compositions and methods for protein production |
| US20060171929A1 (en) * | 2005-01-31 | 2006-08-03 | The University Of Washington | Regulation of dendritic cell functions by the DCAL-2 receptor |
| EP1869206A4 (en) * | 2005-03-02 | 2011-08-10 | Einstein Coll Med | ENZYME SENSORS WITH ENVIRONMENTAL SENSITIVE OR FLUORESCENT LABELS AND APPLICATIONS THEREOF |
| WO2006094073A2 (en) * | 2005-03-02 | 2006-09-08 | Acadia Pharmaceuticals Inc. | Functional bioluminescence energy resonance transfer (bret) assay to screen, identify and characterize receptor tyrosine kinase ligands |
| US8114964B2 (en) * | 2005-05-19 | 2012-02-14 | Centocor, Inc. | Anti-MCP-1 antibodies, compositions, methods and uses |
| WO2007013979A2 (en) * | 2005-07-20 | 2007-02-01 | Invitrogen Corporation | Methods for increasing efficiency of homologous recombination |
| US20080305519A1 (en) * | 2006-02-23 | 2008-12-11 | Qing Lin | Biochemical method for specific protein labeling |
| US20100009352A1 (en) * | 2006-05-24 | 2010-01-14 | Gough Albert H | Method for Modeling a Disease |
| AU2008317354B2 (en) * | 2007-10-25 | 2014-04-10 | Ospedale San Raffaele S.R.L. | Methods and compositions for targeted integration |
| WO2009131632A1 (en) * | 2008-04-14 | 2009-10-29 | Sangamo Biosciences, Inc. | Linear donor constructs for targeted integration |
| KR20160015400A (ko) * | 2008-08-22 | 2016-02-12 | 상가모 바이오사이언스 인코포레이티드 | 표적화된 단일가닥 분할 및 표적화된 통합을 위한 방법 및 조성물 |
-
2011
- 2011-04-13 EP EP11769488.5A patent/EP2558574B1/en active Active
- 2011-04-13 EP EP11769489.3A patent/EP2558575B1/en active Active
- 2011-04-13 US US13/641,050 patent/US20130059362A1/en not_active Abandoned
- 2011-04-13 KR KR1020127028946A patent/KR20130054955A/ko not_active Ceased
- 2011-04-13 BR BR112012026379A patent/BR112012026379A2/pt not_active Application Discontinuation
- 2011-04-13 CA CA2795636A patent/CA2795636C/en active Active
- 2011-04-13 WO PCT/US2011/032214 patent/WO2011130343A1/en not_active Ceased
- 2011-04-13 JP JP2013505077A patent/JP5841996B2/ja active Active
- 2011-04-13 US US13/641,036 patent/US20130065310A1/en not_active Abandoned
- 2011-04-13 CN CN201711044283.XA patent/CN107805278A/zh active Pending
- 2011-04-13 CN CN2011800291603A patent/CN102971421A/zh active Pending
- 2011-04-13 JP JP2013505078A patent/JP5841997B2/ja active Active
- 2011-04-13 WO PCT/US2011/032216 patent/WO2011130345A1/en not_active Ceased
- 2011-04-13 KR KR1020127028401A patent/KR20130055588A/ko not_active Ceased
- 2011-04-13 CA CA2795643A patent/CA2795643C/en active Active
- 2011-04-13 US US13/641,023 patent/US20130059388A1/en not_active Abandoned
- 2011-04-13 CN CN201180029129.XA patent/CN102959078B/zh active Active
- 2011-04-13 DK DK11769489.3T patent/DK2558575T3/en active
- 2011-04-13 WO PCT/US2011/032218 patent/WO2011130346A1/en not_active Ceased
- 2011-04-13 ES ES11769489.3T patent/ES2565216T3/es active Active
-
2017
- 2017-05-31 US US15/609,983 patent/US20180105564A1/en not_active Abandoned
- 2017-07-19 US US15/654,419 patent/US20180134759A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523180A5 (enExample) | ||
| JP2013523181A5 (enExample) | ||
| AR085955A1 (es) | Proteinas de union al antigeno | |
| WO2018073393A3 (en) | Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy | |
| AR095660A1 (es) | Métodos de fabricación para el control el contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes | |
| FI3461261T3 (fi) | Yksiketjuisen vaihtelevan fragmentin sisältäviä cd3:a sitovia proteiineja | |
| BR112013028523A2 (pt) | uso de um anticorpo ou uma proteína de fusão ou um fragmento de ligação da mesma e método para a purificação de um anticorpo, uma proteína de fusão ou um fragmento de ligação da mesma de uma mistura fonte | |
| NZ725079A (en) | Transgene genetic tags and methods of use | |
| NZ608972A (en) | Engineered nucleic acids and methods of use thereof | |
| PE20181044A1 (es) | Anticuerpos anti-pd-1 y composiciones | |
| NZ706377A (en) | Il-6 antagonists and uses thereof | |
| MX2021015182A (es) | Casetes optimizados de expresion del gen humano del factor viii de coagulacion y su uso. | |
| MY162564A (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
| BR112015021819A2 (pt) | Tratamento de câncer utilizando receptor quimérico de antígeno humanizado anti-cd19 | |
| CL2009001001A1 (es) | Anticuerpo anti-factor d del complemento; polinucleotido codificante; vector que comprende dicho polinucleotido; celula huesped que comprende dicho vector; metodo de fabricacion del anticuerpo; composicion farmaceutica que lo comprende; uso del anticuerpo para tratar trastornos inflamatorios o trastornos oculares. | |
| BRPI0612273A2 (pt) | anticorpo de ligaÇço a il-1 beta ou fragmento de ligaÇço a il-1 beta do mesmo, Ácido nucleico, vetor, cÉlula, animal transgÊnico, hibridoma, composiÇço, e, mÉtodos de tratamento ou prevenÇço de uma doenÇa ou doenÇa relacionada a il-1 em um mamÍfero, e de preparaÇço de um polipeptÍdeo de ligaÇço a il-1 beta maturado por afinidade | |
| PE20150023A1 (es) | Proteinas de union a antigeno st2 | |
| AR094141A1 (es) | Composiciones y metodos para proteinas de accion prolongada | |
| MY188761A (en) | Method of reducing serum levels of fc-containing agents using fcrn antagonists | |
| NZ610091A (en) | Antibodies | |
| JP2015532644A5 (enExample) | ||
| WO2011119628A3 (en) | Compositions and methods for self-adjuvanting vaccines against microbes and tumors | |
| MX2011012039A (es) | Anticuerpos bloqueadores anti-dkk-1 y sus usos. | |
| CO6491059A2 (es) | Diferenciacion de las celulas madre mesenquimales | |
| MX2016008520A (es) | Anticuerpo bdca-2 antihumano novedoso. |